Nicotinamide Riboside Hydrogen Malate Market Key Trends Driving Global Growth
Market Overview The Nicotinamide Riboside Hydrogen Malate Market is gaining strong momentum as global consumers increasingly prioritize preventive healthcare, healthy aging, and performance optimization. Nicotinamide riboside (NR), a precursor to NAD+ (nicotinamide adenine dinucleotide), has become widely recognized for its potential to support cellular energy metabolism and longevity. When combined with hydrogen malate, the compound offers improved stability and enhanced bioavailability, making it attractive for dietary supplement manufacturers and pharmaceutical innovators alike. The global Nicotinamide Riboside Hydrogen Malate (NR-HM) market size is predicted to grow from US$ 24.8 million in 2025 to US$ 32.3 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031. Over the past few years, demand for NAD+ boosters has expanded beyond niche biohacking communities into mainstream wellness markets. Consumers are more informed than ever, actively seeking cli...